Seer (NASDAQ:SEER – Get Rating) and Waters (NYSE:WAT – Get Rating) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, profitability and earnings. Valuation & Earnings This table compares Seer and Waters’ top-line revenue, earnings […]
Seer (NASDAQ:SEER – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it contrast to its peers? We will compare Seer to similar companies based on the strength of its earnings, analyst recommendations, risk, institutional ownership, dividends, profitability and valuation. Insider & Institutional Ownership 86.9% of Seer shares […]
Seer (NASDAQ:SEER – Get Rating) and SeqLL (NASDAQ:SQL – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, valuation, profitability, analyst recommendations, earnings and dividends. Insider and Institutional Ownership 86.9% of Seer shares are held by […]
Seer (NASDAQ:SEER – Get Rating) is one of 43 public companies in the “Analytical instruments” industry, but how does it contrast to its peers? We will compare Seer to related businesses based on the strength of its earnings, institutional ownership, analyst recommendations, profitability, valuation, risk and dividends. Analyst Recommendations This is a breakdown of current […]
Seer (NASDAQ:SEER – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it weigh in compared to its competitors? We will compare Seer to similar companies based on the strength of its analyst recommendations, earnings, institutional ownership, risk, dividends, valuation and profitability. Analyst Recommendations This is a summary […]